slyseal28 said:It’s vital to identify the specific type of cancer first. If we're looking at renal cell carcinoma, treatments often include Sutent, Nexavar, or even Avastin. In the US, Sutent is typically covered under specialized insurance lists, though usually just for first-line therapy. You can find more detailed information about treatment options here.
Please try to look closely at what the reports actually state—whether it's the discharge summary, the pathology report, etc.—and let us know.
If it turns out to be transitional cell carcinoma instead, the approach to treatment changes quite a bit.
If it does turn out to be the first type mentioned, I'd strongly suggest seeking a second opinion—either at a different major hospital or through a private specialist.
The findings are listed as follows:
DG: Ca renis 1.sin
OP: nephrectomia radicalis sin
PHD: carcinoma urotheliae infiltrans calices. Adenom renis. Carcinoma metastaticum lymphonodorum 2/12.
To be honest, I'm not an expert on which specific type this refers to, so if anyone could help break this down for me, I'd really appreciate it.
PS. Thank you all so much for the information.